Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anand K. Katakam"'
Autor:
Jingyu Diao, Catrien Bouwman, Donghong Yan, Jing Kang, Anand K. Katakam, Peter Liu, Homer Pantua, Alexander R. Abbas, Nicholas N. Nickerson, Cary Austin, Mike Reichelt, Wendy Sandoval, Min Xu, Chris Whitfield, Sharookh B. Kapadia
Publikováno v:
mBio, Vol 8, Iss 3 (2017)
ABSTRACT Murein lipoprotein (Lpp) and peptidoglycan-associated lipoprotein (Pal) are major outer membrane lipoproteins in Escherichia coli. Their roles in cell-envelope integrity have been documented in E. coli laboratory strains, and while Lpp has b
Externí odkaz:
https://doaj.org/article/749b1c49d18e422d93c20f1e9940a9d9
Autor:
Jingyu Diao, Catrien Bouwman, Donghong Yan, Jing Kang, Anand K. Katakam, Peter Liu, Homer Pantua, Alexander R. Abbas, Nicholas N. Nickerson, Cary Austin, Mike Reichelt, Wendy Sandoval, Min Xu, Chris Whitfield, Sharookh B. Kapadia, Gerald B. Pier
Publikováno v:
mBio
mBio, Vol 8, Iss 3, p e00603-17 (2017)
mBio, Vol 8, Iss 3 (2017)
mBio, Vol 8, Iss 3, p e00603-17 (2017)
mBio, Vol 8, Iss 3 (2017)
Murein lipoprotein (Lpp) and peptidoglycan-associated lipoprotein (Pal) are major outer membrane lipoproteins in Escherichia coli. Their roles in cell-envelope integrity have been documented in E. coli laboratory strains, and while Lpp has been linke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7a0a5ea9771e3527c1de0c95bcf2dda
https://pubmed.ncbi.nlm.nih.gov/28536290
https://pubmed.ncbi.nlm.nih.gov/28536290
Autor:
Ajith R. Vancha, Jagadeesh Gabbeta, Galina Chipitsyna, Donald C. Dafoe, Anand K. Katakam, Qiaoke Gong, Hwyda A. Arafat
Publikováno v:
Endocrinology. 148:575-584
Osteopontin (OPN), a phosphorylated glycoprotein that binds to an integrin-binding motif, has been shown to regulate nitric oxide (NO) production via inhibition of induced NO synthase (iNOS) synthesis. In the transplanted islets, iNOS and toxic amoun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d98818eccdaf90a0f5b0add5d45467
https://doi.org/10.1210/en.2006-0970
https://doi.org/10.1210/en.2006-0970
Autor:
Jennifer L. Friz, Priya R. Baraniak, William R. Wagner, Cory E. Leeson, Jianjun Guan, Yi Hong, Anand K. Katakam, Dean E. Cress, Devin M. Nelson
Publikováno v:
Biomaterials. 32(11)
Gene expression can be controlled in genetically modified cells by employing an inducer/promoter system where presence of the inducer molecule regulates the timing and level of gene expression. By applying the principles of controlled release, it sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::207dd7f85d6cb2597d6f1f0bb076152b
https://pubmed.ncbi.nlm.nih.gov/21269687
https://pubmed.ncbi.nlm.nih.gov/21269687
Publikováno v:
Molecular Therapy. 13
Some gene therapy approaches will require the therapeutic gene to be expressed in a regulated fashion so that the precise amount of the gene product can be delivered in the appropriate tissues at the desired time and for the desired duration. We have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065aedbcf4b2ebe39dd458abfcd5985a
Publikováno v:
Molecular Therapy. 13
The RheoSwitch|[reg]| Therapeutic System (RTS) is used to regulate gene expression in a ligand-dependent manner, and may have utility in human gene therapies that require the specific regulation of the level of gene expression, or where it is desirab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25f713be33489d12a997fd3b70879079
Publikováno v:
Molecular Therapy. 13
The RheoSwitch® Therapeutic System (RTS) is used to regulate gene expression in response to a systemically administered small molecule ligand, or Activator Drug, and may have utility in human gene therapies that require a specifically regulated leve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f141d3ac28492c3ffb8ed977db30261e
Publikováno v:
Molecular Therapy. 11:S409-S410
Top of pageAbstract Different versions of an ecdysone receptor (EcR)-based gene switch that can be regulated by synthetic non-steroid ligands have been developed and reported previously. The most active ligands that are used for regulating these swit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2989caa6e0dce1f8fb0f2f2c5800e546
https://doi.org/10.1016/j.ymthe.2005.07.608
https://doi.org/10.1016/j.ymthe.2005.07.608
Autor:
Dean Ervin Cress, Youngsuk Yi, Anand K. Katakam, Dug Keun Lee, J. Kelly Ganjei, Moon Jong Noh, Kwan Hee Lee, Prasanna Kumar
Publikováno v:
Molecular Therapy. 13:S422
Top of pageAbstract Gene therapy approaches to a variety of diseases will require the therapeutic gene to be expressed in a regulated fashion so that the precise amount of the gene product can be delivered in the appropriate tissues at the desired ti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d63c49f57f3be6cfa8d3ddde1a56310
https://doi.org/10.1016/j.ymthe.2006.08.1200
https://doi.org/10.1016/j.ymthe.2006.08.1200
Publikováno v:
Molecular Therapy. 11:S411
Top of pageAbstract Many gene therapy approaches depend on the expression of heterologous proteins in the appropriate tissue that will exert a therapeutic effect locally or systemically. When the therapeutic protein expressed is intracellular, that w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdbc4d432bab9a115079b5083a292aeb
https://doi.org/10.1016/j.ymthe.2005.07.614
https://doi.org/10.1016/j.ymthe.2005.07.614